24 research outputs found
Analysis and Classification of Oximetry Recordings to Predict Obstructive Sleep Apnea Severity in Children
Producción CientíficaCurrent study is focused around the potential use
of oximetry to determine the obstructive sleep apnea-hypopnea
syndrome (OSAHS) severity in children. Single-channel SpO2
recordings from 176 children were divided into three severity
groups according to the apnea-hypopnea index (AHI): AHI<1
events per hour (e/h), 1≤AHI<5 e/h, and AHI ≥5 e/h. Spectral
analysis was conducted to define and characterize a frequency
band of interest in SpO2. Then we combined the spectral data
with the 3% oxygen desaturation index (ODI3) by means of a
multi-layer perceptron (MLP) neural network, in order to
classify children into one of the three OSAHS severity groups.
Following our MLP multiclass approach, a diagnostic protocol
with capability to reduce the need of polysomnography tests by
46% could be derived. Moreover, our proposal can be also
evaluated, in a binary classification task for two common AHI
diagnostic cutoffs (AHI = 1 e/h and AHI= 5 e/h). High
diagnostic ability was reached in both cases (84.7% and 85.8%
accuracy, respectively) outperforming the clinical variable
ODI3 as well as other measures reported in recent studies.
These results suggest that the information contained in SpO2
could be helpful in pediatric OSAHS severity detection.Junta de Castilla y León (project VA059U13
Nocturnal Oximetry-based Evaluation of Habitually Snoring Children
Rationale: The vast majority of children around the world
undergoing adenotonsillectomy for obstructive sleep
apnea–hypopnea syndrome (OSA) are not objectively diagnosed by
nocturnal polysomnography because of access availability and cost
issues. Automated analysis of nocturnal oximetry (nSpO2), which is
readily and globally available, could potentially provide a reliable and
convenient diagnostic approach for pediatric OSA.
Methods: DeidentifiednSpO2 recordings froma total of 4,191 children
originating from13 pediatric sleep laboratories around the worldwere
prospectively evaluated after developing and validating an automated
neural network algorithm using an initial set of single-channel nSpO2
recordings from 589 patients referred for suspected OSA.
Measurements and Main Results: The automatically
estimated apnea–hypopnea index (AHI) showed high
agreement with AHI from conventional polysomnography
(intraclass correlation coefficient, 0.785) when tested in 3,602
additional subjects. Further assessment on the widely used AHI
cutoff points of 1, 5, and 10 events/h revealed an incremental
diagnostic ability (75.2, 81.7, and 90.2% accuracy; 0.788, 0.854, and
0.913 area under the receiver operating characteristic curve,
respectively).
Conclusions: Neural network–based automated analyses of
nSpO2 recordings provide accurate identification of OSA
severity among habitually snoring children with a high pretest
probability of OSA. Thus, nocturnal oximetry may enable a
simple and effective diagnostic alternative to nocturnal
polysomnography, leading to more timely interventions and
potentially improved outcomes.Supported in part by project VA037 U16 from the Consejer´ıa de Educacio´ n de la Junta de Castilla y Leo´ n and the European Regional Development Fund (FEDER), project RTC-2015-3446-1 from the Ministerio de Econom´ıa y Competitividad and FEDER, and project 153/2015 of the Sociedad Espan˜ ola de Neumolog´ıa y Cirug´ıa Tora´ cica (SEPAR). L.K.-G. is supported by NIH grant 1R01HL130984. M.F.P. was supported by a Fellowship Educational grant award from the Kingdom of Saudi Arabia. D.´A. was in receipt of a Juan de la Cierva grant from the Ministerio de Econom´ıa y Competitividad. The funders played no role in the study design, data collection, data analysis, interpretation, and writing of the manuscript
Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome : Insights from the LUNG SAFE study
Publisher Copyright: © 2020 The Author(s). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.Background: Concerns exist regarding the prevalence and impact of unnecessary oxygen use in patients with acute respiratory distress syndrome (ARDS). We examined this issue in patients with ARDS enrolled in the Large observational study to UNderstand the Global impact of Severe Acute respiratory FailurE (LUNG SAFE) study. Methods: In this secondary analysis of the LUNG SAFE study, we wished to determine the prevalence and the outcomes associated with hyperoxemia on day 1, sustained hyperoxemia, and excessive oxygen use in patients with early ARDS. Patients who fulfilled criteria of ARDS on day 1 and day 2 of acute hypoxemic respiratory failure were categorized based on the presence of hyperoxemia (PaO2 > 100 mmHg) on day 1, sustained (i.e., present on day 1 and day 2) hyperoxemia, or excessive oxygen use (FIO2 ≥ 0.60 during hyperoxemia). Results: Of 2005 patients that met the inclusion criteria, 131 (6.5%) were hypoxemic (PaO2 < 55 mmHg), 607 (30%) had hyperoxemia on day 1, and 250 (12%) had sustained hyperoxemia. Excess FIO2 use occurred in 400 (66%) out of 607 patients with hyperoxemia. Excess FIO2 use decreased from day 1 to day 2 of ARDS, with most hyperoxemic patients on day 2 receiving relatively low FIO2. Multivariate analyses found no independent relationship between day 1 hyperoxemia, sustained hyperoxemia, or excess FIO2 use and adverse clinical outcomes. Mortality was 42% in patients with excess FIO2 use, compared to 39% in a propensity-matched sample of normoxemic (PaO2 55-100 mmHg) patients (P = 0.47). Conclusions: Hyperoxemia and excess oxygen use are both prevalent in early ARDS but are most often non-sustained. No relationship was found between hyperoxemia or excessive oxygen use and patient outcome in this cohort. Trial registration: LUNG-SAFE is registered with ClinicalTrials.gov, NCT02010073publishersversionPeer reviewe
Electrospun Poly(acrylic acid-co-4-styrene sulfonate) as Potential Drug-Eluting Scaffolds for Targeted Chemotherapeutic Delivery Systems on Gastric (AGS) and Breast (MDA-Mb-231) Cancer Cell Lines
Potential drug-eluting scaffolds of electrospun poly(acrylic acid-co-styrene sulfonate) P(AA-co-SS) in clonogenic assays using tumorigenic gastric and ovarian cancer cells were tested in vitro. Electrospun polymer nanofiber (EPnF) meshes of PAA and PSSNa homo- and P(AA-co-SS) copolymer composed of 30:70, 50:50, 70:30 acrylic acid (AA) and sodium 4-styrene sulfonate (SSNa) units were performed by electrospinning (ES). The synthesis, structural and morphological characterization of all EPnF meshes were analyzed by optical and electron microscopy (SEM-EDS), infrared spectroscopy (FTIR), contact angle, and X-ray diffraction (XRD) measurements. This study shows that different ratio of AA and SSNa of monomers in P(AA-co-SS) EPnF play a crucial role in clonogenic in vitro assays. We found that 50:50 P(AA-co-SS) EPnF mesh loaded with antineoplastic drugs can be an excellent suppressor of growth-independent anchored capacities in vitro assays and a good subcutaneous drug delivery system for chemotherapeutic medication in vivo model for surgical resection procedures in cancer research
Congreso Nacional SEPAR (49º. 2016. Granada)
Producción CientíficaEl síndrome de apnea hipopnea obstructiva del sueño (SAHS) en niños se ha convertido en un problema médico frecuente en las últimas 2-3 décadas. Es una patología que si no se trata se asocia a comorbilidades graves relacionadas con el sistema nervioso central y los sistemas cardiovascular y metabólico. La PSG hospitalaria es la prueba gold standard para su diagnóstico, pero es una técnica compleja, costosa y a veces inaccesible. La SpO2 de la pulsioximetría nocturna podría proporcionar información simplificando el proceso diagnóstico. El objetivo de nuestro estudio ha sido diseñar y evaluar un clasificador automatizado destinado a diagnosticar el SAHS.Junta de Castilla y León (programa de apoyo a proyectos de investigación – Ref. VA302U13
Rentabilidad de la tomografia axial cerebral en el estadiaje inicial del carcinoma broncogenico
Patologia respiratoria en el sindrome toxico por ingestion de aceite de colza desnaturalizado
ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up
The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically relevant questions about endometrial cancer relating to the following four areas: prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article. © The Author 2015